Abstract: Methods, systems and computer storage media are disclosed for providing resources to a platform issue. Embodiments describe associating educational resources and an event resource to resolve the platform issue.

Abstract: Methods, systems and computer storage media are disclosed for providing resources to a platform issue. Embodiments describe associating educational resources and an event resource to resolve the platform issue.

Abstract: Methods, systems and computer storage media are disclosed for providing resources to a platform issue. Embodiments describe associating educational resources and an event resource to resolve the platform issue.

Abstract: Methods, systems and computer storage media are disclosed for providing resources to a platform issue. Embodiments describe associating educational resources and an event resource to resolve the platform issue.

Abstract: Methods, systems, and computer-readable media are disclosed herein that provide a comprehensive view that reveals all or nearly all possible method dependencies that are present in client workflows. In aspects, when computer code for a particular method is going to be edited, other methods are identified that have upstream or downstream dependencies relative to the particular method. The methods that will be affected based on the computer code editing can be presented in a user-interactive graphical user interface that facilitates exploration of upstream and downstream dependencies.

Abstract: Described herein are carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity.

Abstract: Described herein are carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity. Such carboxamide derivatives form bicyclic and tricyclic ring systems and the disease or condition associated with RSK activity in a mammal is cancer.

Abstract: Described herein are carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity. Such carboxamide derivatives form bicyclic and tricyclic ring systems and the disease or condition associated with RSK activity in a mammal is cancer.

Abstract: Described herein are carboxamide derivatives of Formula (II) that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity: wherein R2, R4a, R4b, R11, R12, and n are defined in the specification.

Abstract: Described herein are carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity.

Abstract: Described herein are carboxamide derivatives of Formula (II) that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity: wherein R2, R4a, R4b, R11, R12, and n are defined in the specification.

Abstract: Described herein are carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK), pharmaceutical compositions comprising the derivatives, and methods of using the derivatives in treating diseases or conditions associated with RSK activity.

Abstract: A system for heat-treatment of large metallic samples including a microwave heating apparatus with a wave guide, means for monitoring and measuring temperature, holding means for holding the metallic sample. The holding means comprises a casket configuration made of low density alumina fiber board and wrapped with low density alumina fiber material to define a cavity and provided with susceptors along the inner walls of the cavity.

Abstract: A chromium-molybdenum-vanadium (Cr—Mo—V) cast steel including 0.04 to 0.08% by weight of niobium is disclosed. The cast steel may include 0.08 to 0.12% by weight carbon. The cast steel may also have a sulphur content of 0.015% by weight or less, and a phosphorus content of 0.02% by weight or less. The silicon content may be 0.30 to 0.60% by weight, the manganese content may be 0.50 to 0.80% by weight, the chromium content may be 1.20 to 1.50% by weight, the molybdenum content may be 0.90 to 1.10% by weight, and the vanadium content may be 0.20 to 0.30% by weight.

Abstract: A system for heat-treatment of large metallic samples including a microwave heating apparatus with a wave guide, means for monitoring and measuring temperature, holding means for holding the metallic sample. The holding means comprises a casket configuration made of low density alumina fiber board and wrapped with low density alumina fiber material to define a cavity and provided with susceptors along the inner walls of the cavity.

Abstract: A chromium-molybdenum-vanadium (Cr—Mo—V) cast steel including 0.04 to 0.08% by weight of niobium is disclosed. The cast steel may include 0.08 to 0.12% by weight carbon. The cast steel may also have a sulphur content of 0.015% by weight or less, and a phosphorus content of 0.02% by weight or less. The silicon content may be 0.30 to 0.60% by weight, the manganese content may be 0.50 to 0.80% by weight, the chromium content may be 1.20 to 1.50% by weight, the molybdenum content may be 0.90 to 1.10% by weight, and the vanadium content may be 0.20 to 0.30% by weight.

Abstract: A process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives of general formula I: or their pharmaceutically acceptable salts, wherein the meaning of X is hydrogen, carboxyl, alkoxycarbonyl, aryloxycarbonyl, nitrile, or carbamoyl of formula wherein R1 and R2 can be individually or simultaneously hydrogen, alkyl or part of a heterocyclic structure; Z can be hydrogen, halogen, alkyl, aryl, aryloxy or alkoxy group.